Legal & Compliance

DOL Issues Field Assistance Bulletin Outlining Mental Health Parity Enforcement Approach

The United States Department of Labor’s Employee Benefits Security Administration has officially released comprehensive guidance detailing its updated strategy for enforcing mental health parity laws across employer-sponsored group health plans. The directive, designated as Field Assistance Bulletin No. 2026-03, was published on September 12, 2026, following its initial issuance on September 8, 2026. This regulatory update arrives at a critical juncture for employee benefits administration, offering much-needed clarity to plan sponsors, administrators, and fiduciaries who have navigated a complex landscape of legislative changes, sweeping final rules, and subsequent federal litigation over the past several years.

Under the new Field Assistance Bulletin, commonly referred to as the FAB, the EBSA is formally narrowing the scope of its nonquantitative treatment limitation comparative analysis enforcement efforts. Rather than auditing every facet of mental health and substance use disorder parity simultaneously, federal investigators will concentrate resources on three primary enforcement categories. These prioritized areas include separate treatment limitations and blanket exclusions of mental health and substance use disorder benefits, medical necessity standards and review processes, and network adequacy standards—specifically encompassing network admission criteria and provider reimbursement methodologies.

While this targeted approach aims to streamline regulatory oversight and protect plan participants from severe coverage disparities, the release of the FAB also underscores the ongoing legal and administrative challenges defining modern healthcare compliance. Group health plan sponsors must carefully evaluate their fiduciary obligations to ensure continued adherence to foundational statutory requirements, even as federal agencies adapt their enforcement posture in response to ongoing courtroom battles over broader regulatory overhauls.

Legislative Roots and the Evolution of Mental Health Parity

To fully understand the significance of Field Assistance Bulletin No. 2026-03, it is essential to examine the historical framework governing mental health and substance use disorder benefits in the United States. The foundational statute, the Mental Health Parity and Addiction Equity Act, was enacted to prevent group health plans and health insurance issuers from imposing more restrictive financial requirements or treatment limitations on mental health and substance use disorder benefits than those applied to medical and surgical benefits.

For years, compliance with the MHPAEA primarily focused on quantitative limitations, such as copayments, coinsurance, deductibles, and visit limits. However, advocates and regulators increasingly recognized that health plans could effectively restrict access to behavioral healthcare through nonquantitative treatment limitations. NQTLs include a wide variety of operational practices, such as prior authorization requirements, concurrent review protocols, standards for provider admission to networks, prescription drug formulary designs, and methods for determining out-of-network reimbursement rates.

The regulatory landscape shifted dramatically with the passage of the Consolidated Appropriations Act, 2021. The CAA, 2021 introduced a statutory mandate requiring group health plans and health insurers offering group or individual health insurance coverage to design, document, and maintain written comparative analyses of the design and application of NQTLs. These documents must explicitly demonstrate that the processes, strategies, evidentiary standards, and other factors used to apply NQTLs to mental health and substance use disorder benefits are comparable to, and no more stringent than, those applied to medical and surgical benefits. Furthermore, plans are legally obligated to make these comprehensive comparative analyses available to federal regulators, state insurance commissioners, and plan participants upon request.

The 2024 Final Rule and Subsequent Legal Challenges

Following the enactment of the CAA, 2021, federal agencies moved quickly to codify detailed standards for NQTL comparative analyses. On September 9, 2024, the Department of Labor, the Department of Health and Human Services, and the Department of the Treasury jointly released comprehensive final regulations governing the MHPAEA. These 2024 Final Rules introduced rigorous new requirements, expanding the scope of data collection, mandating extensive evidentiary standards, and requiring plan fiduciaries to certify compliance. The rules placed an immediate, heavy administrative burden on plan sponsors, with compliance deadlines slated to begin rolling out in 2025.

However, the regulatory rollout faced immediate and aggressive pushback from the business and healthcare communities. Major industry associations, employer coalitions, and corporate legal teams filed lawsuits challenging the validity of the 2024 Final Rule, arguing that the tripartite departments had exceeded their statutory authority under the original MHPAEA and the CAA, 2021, and that the new evidentiary requirements were arbitrary, capricious, and overly burdensome.

Recognizing the widespread uncertainty caused by the ongoing litigation, the federal departments issued a broad non-enforcement policy on May 15, 2025. Under this policy, the agencies announced they would not enforce provisions of the 2024 Final Rule that represented new obligations relative to the older 2013 Final Rule. This enforcement moratorium was structured to remain in effect pending a final, non-appealable judicial decision in the active litigation, plus an additional 18-month grace period to allow plan sponsors adequate time to adapt once the legal dust settled.

Despite this suspension of the newer 2024 rules, federal authorities emphasized that the underlying statutory obligations of the MHPAEA—including the foundational parity requirements and the NQTL comparative analysis mandates established by the CAA, 2021—remained fully in effect. Plan sponsors retained the ongoing legal duty to prepare, maintain, and produce NQTL comparative analyses upon request, typically within a strict ten-business-day window following a regulatory inquiry.

Key Provisions of Field Assistance Bulletin No. 2026-03

Field Assistance Bulletin No. 2026-03 serves two critical functions within this complex regulatory environment. First, it formally reiterates and operationalizes the non-enforcement policy regarding the novel aspects of the 2024 Final Rule, confirming that EBSA investigators will not penalize plans for failing to meet standards that extend beyond the 2013 regulatory baseline while the litigation remains unresolved. Second, and perhaps most importantly, it establishes a transparent framework for how EBSA will allocate its investigative resources when reviewing existing statutory comparative analysis requirements.

According to the FAB, EBSA will strategically narrow its NQTL enforcement focus to three core areas deemed to present the highest potential for significant harm to participants and beneficiaries:

  1. Separate Treatment Limitations and Blanket Exclusions: Investigators will scrutinize plan designs that impose separate restrictions on behavioral health care or completely exclude specific categories of mental health and substance use disorder treatments, such as residential treatment center coverage or applied behavior analysis therapy, without a valid medical or surgical counterpart.
  2. Medical Necessity Standards and Review Processes: EBSA will evaluate the criteria used by health plans and third-party administrators to determine whether mental health services are medically necessary. This includes examining prior authorization protocols, concurrent review standards, and the clinical guidelines utilized by utilization review entities to ensure they do not unfairly restrict behavioral health claims compared to medical claims.
  3. Network Adequacy Standards and Provider Reimbursement: The agency will closely review standards governing provider network admission, credentialing processes, and reimbursement methodologies. Given persistent nationwide shortages of in-network mental health professionals, regulators are increasingly focused on whether low reimbursement rates and burdensome administrative barriers effectively exclude mental health providers from participating in health plan networks.

While the FAB highlights these three priority categories, it includes a crucial caveat: EBSA retains the authority to investigate other categories of NQTLs if specific complaints, plan documentation, or preliminary findings suggest systemic violations that could severely impact plan participants. Consequently, while the bulletin signals a prioritized enforcement strategy, it does not grant plan sponsors a blanket exemption from maintaining comprehensive compliance across all operational aspects of their health plans.

Implications for Plan Sponsors, Fiduciaries, and Employers

The release of EBSA Field Assistance Bulletin No. 2026-03 carries significant practical implications for employers who sponsor group health plans, as well as third-party administrators, insurance carriers, and benefits consultants. While the targeted enforcement approach offers a degree of operational relief by clarifying where federal investigators will direct their immediate attention, legal and compliance experts stress that complacency is not an option.

Plan fiduciaries must continue to treat mental health parity compliance as an active, ongoing responsibility. The statutory mandate under the CAA, 2021, requiring plans to possess and maintain robust NQTL comparative analyses, remains fully enforceable. Furthermore, when federal investigators request these documents during a routine audit or in response to a participant complaint, plans must be prepared to produce them within the statutory ten-day window. Failure to provide a legally sufficient comparative analysis can lead to substantial civil monetary penalties, participant lawsuits, and mandated plan corrective actions.

In light of the new guidance, employee benefits professionals recommend that plan sponsors undertake several proactive measures:

  • Audit Existing NQTL Documentation: Sponsors should review their current comparative analyses to ensure they thoroughly address the three priority areas highlighted in the FAB—specifically examining medical necessity criteria, network adequacy metrics, and any separate limitations applied to mental health or substance use disorder benefits.
  • Coordinate with Third-Party Administrators: Because most self-insured employer plans rely heavily on third-party administrators and managed behavioral health organizations to design and administer benefit structures, sponsors must actively collaborate with these vendors to obtain the necessary data, evidentiary standards, and comparative analysis documentation.
  • Monitor Ongoing Litigation: Fiduciaries must keep a close watch on the federal court system as the legal challenges surrounding the 2024 Final Rule progress, preparing for eventual shifts in regulatory enforcement once a final judicial resolution is reached and the post-litigation grace period begins to wind down.

As the Department of Labor continues to refine its oversight mechanisms through directives like Field Assistance Bulletin No. 2026-03, the overarching federal commitment to enforcing mental health parity remains resolute. Plan sponsors who maintain rigorous documentation, prioritize high-risk operational areas, and actively partner with their administrative service providers will be best positioned to navigate the evolving regulatory landscape while safeguarding access to essential behavioral healthcare for American workers and their families.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button